Methotrexate and temozolomide versus methotrexate, procarbazine, vincristine, and cytarabine for primary CNS lymphoma in an elderly population: an intergroup ANOCEF-GOELAMS randomised phase 2 trial

This publication has 31 references indexed in Scilit:

• Intensive Chemotherapy and Immunotherapy in Patients With Newly Diagnosed Primary CNS Lymphoma: CALGB 50202 (Alliance 50202)
  Journal of Clinical Oncology, 2013
• Age, gender, and racial differences in incidence and survival in primary CNS lymphoma
  British Journal of Cancer, 2011
• High-dose methotrexate for elderly patients with primary CNS lymphoma
  Neuro-Oncology, 2009
• High-dose methotrexate combined with procarbazine and CCNU for primary CNS lymphoma in the elderly: results of a prospective pilot and phase II study
  Annals of Oncology, 2008
• Intensive Chemotherapy Followed by Hematopoietic Stem-Cell Rescue for Refractory and Recurrent Primary CNS and Intraocular Lymphoma: Société Française de Greffe de Moëlle Osseuse-Thérapie Cellulaire
  Journal of Clinical Oncology, 2008
• Temozolomide as salvage treatment in primary brain lymphomas
  British Journal of Cancer, 2007
• Immunochemotherapy with rituximab and temozolomide for central nervous system lymphomas
  Cancer, 2004
• Chemotherapy Alone as Initial Treatment for Primary CNS Lymphoma in Patients Older Than 60 Years: A Multicenter Phase II Study (26952) of the European Organization for Research and Treatment of Cancer Brain Tumor Group
  Journal of Clinical Oncology, 2003
• High-dose methotrexate for primary CNS lymphoma in the elderly
  Neuro-Oncology, 2000
• The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology
  JNCI: Journal of the National Cancer Institute, 1993